MA Yaxin1, LI Shuqiong1, LI Yunxiang1, SUN Yonghong2▲

Corresponding author: Sun Yonghong, Sunyonghong7615@126.com

DOI: 10.12201/bmr.202504.00073

•  

  Abstract: Mycoplasma pneumoniae pneumonia (MPP) is one of the leading pathogens of community-acquired pneumonia (CAP) in children, with a significantly increasing incidence in recent years. The proportion of severe MPP cases has also been rising, making it a major focus of clinical research due to its severe condition, rapid progression, treatment challenges, and high risk of complications. Recent studies have demonstrated that serological biomarkers play a crucial role in the early identification and disease assessment of severe MPP, including C-reactive protein (CRP), procalcitonin (PCT), erythrocyte sedimentation rate (ESR), D-dimer (D-D), lactate dehydrogenase (LDH), and tumor necrosis factor-alpha (TNF-α). This review summarizes recent research on the early prediction of severe MPP in children, providing valuable insights for its early diagnosis.

  Key words: Mycoplasma pneumoniae pneumonia; severe mycoplasma pneumoniae pneumonia; early prediction; research progress

  Submit time: 27 April 2025

  Copyright: The copyright holder for this preprint is the author/funder, who has granted biomedRxiv a license to display the preprint in perpetuity.
• html

• 图表

• YE Hongzhou, YUAN Chen. Risk factors of severe pneumonia in children with macrolide-resistant Mycoplasma pneumoniae pneumonia and the construction of prediction model. 2024. doi: 10.12201/bmr.202409.00021

  Lu jianliang, Feng yuan, Lu yanling. Analysis of clinical characteristics of severe mycoplasma pneumoniae pneumonia in children. 2025. doi: 10.12201/bmr.202505.00038

  changyanmei, yulijuan, 孟淑萍. The value of Mycoplasma pneumoniae RNA detection in the diagnosis and treatment of Mycoplasma pneumoniae pneumonia in children. 2025. doi: 10.12201/bmr.202506.00025

  ZHANG Xiao-Hua, YANG Yi-Tong. Progress of community-acquired respiratory distress syndrome toxins in Mycoplasma pneumoniae infection in children. 2025. doi: 10.12201/bmr.202506.00057

  GENG Gang, LI Shaojun. Mycoplasma pneumoniae encephalitis in children: a case report and literature review. 2024. doi: 10.12201/bmr.202408.00042

  Li Feifan, Zhang shuitang. Impact of Mixed Infections and Antibiotic Resistance Genes on Clinical Features in Children with Mycoplasma pneumoniae Pneumonia. 2024. doi: 10.12201/bmr.202412.00025

  Wu Xiayang. Evaluation of the effectiveness and safety of generic and original azithromycin for the treatment of pediatric mycoplasma pneumonia. 2025. doi: 10.12201/bmr.202501.00071

  周妮, GU Qiang. Risk factors and risk prediction for the course of lobar pneumonia in children. 2025. doi: 10.12201/bmr.202504.00059

  Zhang Lina, Zhang qiuyue, Li Zhen, Tian Jia. Changes and Significance of Coagulation Function Indicators in Elderly Patients with Severe Pneumonia. 2024. doi: 10.12201/bmr.202411.00035

  . 2024. doi: 10.12201/bmr.202411.00065

• ID	Submit time	Number	Download
  1	2025-03-14	bmr.202504.00073V1	Download

• Public  Anonymous  To author only Submit Comments